当科のチロシンキナーゼ阻害薬登場後のフィラデルフィア染色体陽性造血器腫瘍9例の治療成績 Current management of Philadelphia chromosome-positive hematological malignancy in the era of tyrosine kinase inhibitors: A single institute experience